Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.

Wakefield TW, Strieter RM, Schaub R, Myers DD, Prince MR, Wrobleski SK, Londy FJ, Kadell AM, Brown SL, Henke PK, Greenfield LJ.

J Vasc Surg. 2000 Feb;31(2):309-24.

2.

P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model.

Myers DD Jr, Henke PK, Wrobleski SK, Hawley AE, Farris DM, Chapman AM, Knipp BS, Thanaporn P, Schaub RG, Greenfield LJ, Wakefield TW.

J Vasc Surg. 2002 Nov;36(5):928-38.

PMID:
12422103
3.

Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis.

Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, Hulin MS, Kadell AM, Wilke CA, Brown SL, Wrobleski SK, Burdick MD, Anderson DC, Greenfield LJ.

J Vasc Surg. 1997 May;25(5):816-27; discussion 828.

4.

P-selectin antagonism causes dose-dependent venous thrombosis inhibition.

Myers DD Jr, Schaub R, Wrobleski SK, Londy FJ 3rd, Fex BA, Chapman AM, Greenfield LJ, Wakefield TW.

Thromb Haemost. 2001 Mar;85(3):423-9.

PMID:
11307808
5.

New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig.

Myers D, Wrobleski S, Londy F, Fex B, Hawley A, Schaub R, Greenfield L, Wakefield T.

Thromb Haemost. 2002 Mar;87(3):374-82.

PMID:
11916067
6.

P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model.

Thanaporn P, Myers DD, Wrobleski SK, Hawley AE, Farris DM, Wakefield TW, Henke PK.

Surgery. 2003 Aug;134(2):365-71.

PMID:
12947342
7.

Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation.

Myers DD Jr, Wrobleski SK, Longo C, Bedard PW, Kaila N, Shaw GD, Londy FJ, Rohrer SE, Fex BA, Zajkowski PJ, Meier TR, Hawley AE, Farris DM, Ballard NE, Henke PK, Schaub RG, Wakefield TW.

Thromb Haemost. 2007 Mar;97(3):400-7.

PMID:
17334507
8.

P-selectin and leukocyte microparticles are associated with venous thrombogenesis.

Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, Wagner DD, Kumar A, Wakefield TW.

J Vasc Surg. 2003 Nov;38(5):1075-89. Erratum in: J Vasc Surg. 2004 Jan;39(1):188.

9.

Decreased venous thrombosis with an oral inhibitor of P selectin.

Myers DD Jr, Rectenwald JE, Bedard PW, Kaila N, Shaw GD, Schaub RG, Farris DM, Hawley AE, Wrobleski SK, Henke PK, Wakefield TW.

J Vasc Surg. 2005 Aug;42(2):329-36.

10.

P-Selectin-dependent inhibition of thrombosis during venous stasis.

Eppihimer MJ, Schaub RG.

Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2483-8.

11.

A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model.

Amersi F, Dulkanchainun T, Nelson SK, Farmer DG, Kato H, Zaky J, Melinek J, Shaw GD, Kupiec-Weglinski JW, Horwitz LD, Horwitz MA, Busuttil RW.

Transplantation. 2001 Jan 15;71(1):112-8.

PMID:
11211175
12.

Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.

Myers DD Jr, Henke PK, Bedard PW, Wrobleski SK, Kaila N, Shaw G, Meier TR, Hawley AE, Schaub RG, Wakefield TW.

J Vasc Surg. 2006 Sep;44(3):625-32.

13.

Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model.

Kumar A, Villani MP, Patel UK, Keith JC Jr, Schaub RG.

Circulation. 1999 Mar 16;99(10):1363-9.

14.

P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.

Ramacciotti E, Myers DD Jr, Wrobleski SK, Deatrick KB, Londy FJ, Rectenwald JE, Henke PK, Schaub RG, Wakefield TW.

Thromb Res. 2010 Apr;125(4):e138-42. doi: 10.1016/j.thromres.2009.10.022. Epub 2009 Dec 4.

15.

P-selectin inhibition therapeutically promotes thrombus resolution and prevents vein wall fibrosis better than enoxaparin and an inhibitor to von Willebrand factor.

Diaz JA, Wrobleski SK, Alvarado CM, Hawley AE, Doornbos NK, Lester PA, Lowe SE, Gabriel JE, Roelofs KJ, Henke PK, Schaub RG, Wakefield TW, Myers DD Jr.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):829-37. doi: 10.1161/ATVBAHA.114.304457. Epub 2015 Feb 5.

16.

Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.

Meier TR, Myers DD Jr, Wrobleski SK, Zajkowski PJ, Hawley AE, Bedard PW, Ballard NE, Londy FJ, Kaila N, Vlasuk GP, Schaub RG, Wakefield TW.

Thromb Haemost. 2008 Feb;99(2):343-51. doi: 10.1160/TH07-10-0608.

PMID:
18278184
17.

Detection of perivenous inflammation in a rat model of venous thrombosis using MRV.

Londy FJ, Kadell AM, Wrobleski SK, Prince MR, Strieter RM, Wakefield TW.

J Invest Surg. 1999 May-Jun;12(3):151-6.

PMID:
10421517
18.

Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1.

Tanguay JF, Geoffroy P, Sirois MG, Libersan D, Kumar A, Schaub RG, Merhi Y.

Thromb Haemost. 2004 Jun;91(6):1186-93.

PMID:
15175806
19.
20.

Supplemental Content

Support Center